User:W
From Pubdrug
(List of links)
< User:WThe following pages link to here:
View (previous 50) (next 50) (20 | 50 | 100 | 250 | 500).- Talk:Atorvastatin
- Talk:Amlodipine
- Talk:Hydrocodone Bitartrate and Acetaminophen
- Talk:Alzheimer's Agents
- Collaborative Atorvastatin Diabetes Study (CARDS)
- Talk:Intensive Blood-Glucose Control With Metformin (UKPDS 34)
- Talk:Collaborative Atorvastatin Diabetes Study (CARDS)
- Talk:The PROactive Study: PROspective pioglitAzone Clinical Trial In macroVascluar Events
- Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET)
- Talk:Antihyperglycemic Agents
- Talk:Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
- Talk:Top 200 Drugs
- Effect of Niacin on Lipid Levels and Glycemic Control in Patients With Diabetes: The ADMIT Study
- Talk:Effect of Niacin on Lipid Levels and Glycemic Control in Patients With Diabetes: The ADMIT Study
- Talk:Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET)
- Talk:Renoprotective Effect of Irbesartan in Patients With Nephropathy due to Type 2 Diabetes
- Talk:Anglo-Scandinavian Cardiac Outcomes Trial - Lipid Lowering Arm (ASCOT-LLA)
- Template:EBM blue
- Talk:Carvedilol or Metoprolol European Trial (COMET)
- Talk:Effect of risedronate on the risk of hip fracture in elderly women (HIP)
- Talk:Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
- Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance
- Pubdrug talk:Categorical index
- Talk:A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients with Type 2 Diabetes
- Talk:Cardiometabolic Risk in Impaired Fasting Glucose and Impaired Glucose Tolerance
- Acyclovir drug interactions
- Talk:Acyclovir drug interactions
- Talk:Atomoxetine
- Talk:Rosiglitazone
- Talk:Monograph Template
